ECSP088801A - Composicion farmaceutica que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b para el tratamiento de la neuralgia - Google Patents
Composicion farmaceutica que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b para el tratamiento de la neuralgiaInfo
- Publication number
- ECSP088801A ECSP088801A EC2008008801A ECSP088801A ECSP088801A EC SP088801 A ECSP088801 A EC SP088801A EC 2008008801 A EC2008008801 A EC 2008008801A EC SP088801 A ECSP088801 A EC SP088801A EC SP088801 A ECSP088801 A EC SP088801A
- Authority
- EC
- Ecuador
- Prior art keywords
- complex
- neuralgia
- treatment
- salt
- ketorolaco
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a las combinaciones farmacéuticas de sal de ketorolaco y complejo B; a métodos para la fabricación de dichas combinaciones; y particularmente, a las combinaciones sinérgicas de ketorolaco y complejo B útiles en el tratamiento de pacientes que sufren de dolor moderado a severo y neuralgias de diversa localización
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXPA/A/2006/004020A MXPA06004020A (es) | 2006-04-10 | Composicion farmaceutica que comprende un analgesico y vitaminas |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP088801A true ECSP088801A (es) | 2009-01-30 |
Family
ID=38580737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2008008801A ECSP088801A (es) | 2006-04-10 | 2008-10-08 | Composicion farmaceutica que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b para el tratamiento de la neuralgia |
Country Status (16)
Country | Link |
---|---|
US (1) | US20090227534A1 (es) |
EP (1) | EP2008655B1 (es) |
JP (1) | JP5244089B2 (es) |
AR (1) | AR060394A1 (es) |
BR (1) | BRPI0709967A2 (es) |
CA (1) | CA2649194C (es) |
CO (1) | CO6331430A2 (es) |
CR (1) | CR10360A (es) |
DO (1) | DOP2007000055A (es) |
EC (1) | ECSP088801A (es) |
ES (1) | ES2428342T3 (es) |
GT (1) | GT200800208A (es) |
HN (1) | HN2008001531A (es) |
PE (2) | PE20120122A1 (es) |
PL (1) | PL2008655T3 (es) |
WO (1) | WO2007116287A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2008003230A (es) * | 2008-03-07 | 2009-09-07 | Senosiain S A De C V Lab | Composicion famaceutica oral que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b. |
ES2753981T3 (es) * | 2010-10-21 | 2020-04-15 | Rtu Pharmaceuticals Llc | Formulaciones de ketorolaco listas para uso |
AU2013201465B2 (en) * | 2012-10-24 | 2016-03-03 | Rayner Surgical (Ireland) Limited | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
TWI705812B (zh) | 2014-12-01 | 2020-10-01 | 奥默羅斯公司 | 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2823167A (en) * | 1955-03-29 | 1958-02-11 | Vitarine Co Inc | Stable vitamin b12-containing solution |
FR4492M (es) * | 1965-07-07 | 1966-10-10 | ||
US4579846A (en) * | 1984-10-11 | 1986-04-01 | Pfizer Inc. | Antiinflammatory compositions and methods |
US6051587A (en) | 1998-04-16 | 2000-04-18 | Medicure, Inc. | Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein |
US20030191187A1 (en) * | 2002-04-01 | 2003-10-09 | Lee Fang Yu | Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
MXPA02010828A (es) | 2002-11-04 | 2004-07-16 | Leopoldo Espinosa Abdala | Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor. |
-
2007
- 2007-03-22 DO DO2007000055A patent/DOP2007000055A/es unknown
- 2007-04-09 PE PE2011001166A patent/PE20120122A1/es active IP Right Grant
- 2007-04-09 PE PE2007000424A patent/PE20080363A1/es not_active Application Discontinuation
- 2007-04-10 ES ES07734226T patent/ES2428342T3/es active Active
- 2007-04-10 AR ARP070101491A patent/AR060394A1/es not_active Application Discontinuation
- 2007-04-10 US US12/226,219 patent/US20090227534A1/en not_active Abandoned
- 2007-04-10 JP JP2009504843A patent/JP5244089B2/ja not_active Expired - Fee Related
- 2007-04-10 EP EP07734226.9A patent/EP2008655B1/en not_active Not-in-force
- 2007-04-10 CA CA2649194A patent/CA2649194C/en not_active Expired - Fee Related
- 2007-04-10 WO PCT/IB2007/000907 patent/WO2007116287A1/es active Application Filing
- 2007-04-10 BR BRPI0709967-3A patent/BRPI0709967A2/pt not_active IP Right Cessation
- 2007-04-10 PL PL07734226T patent/PL2008655T3/pl unknown
-
2008
- 2008-10-08 EC EC2008008801A patent/ECSP088801A/es unknown
- 2008-10-09 GT GT200800208A patent/GT200800208A/es unknown
- 2008-10-10 CO CO08108827A patent/CO6331430A2/es not_active Application Discontinuation
- 2008-10-10 HN HN2008001531A patent/HN2008001531A/es unknown
- 2008-10-10 CR CR10360A patent/CR10360A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP5244089B2 (ja) | 2013-07-24 |
BRPI0709967A2 (pt) | 2011-08-02 |
CO6331430A2 (es) | 2011-10-20 |
ES2428342T3 (es) | 2013-11-07 |
EP2008655A1 (en) | 2008-12-31 |
CA2649194C (en) | 2014-12-30 |
HN2008001531A (es) | 2011-07-12 |
JP2009533413A (ja) | 2009-09-17 |
GT200800208A (es) | 2010-03-18 |
PE20120122A1 (es) | 2012-03-09 |
AR060394A1 (es) | 2008-06-11 |
WO2007116287A1 (es) | 2007-10-18 |
CA2649194A1 (en) | 2007-10-18 |
PL2008655T3 (pl) | 2013-11-29 |
DOP2007000055A (es) | 2007-10-31 |
EP2008655B1 (en) | 2013-06-26 |
US20090227534A1 (en) | 2009-09-10 |
PE20080363A1 (es) | 2008-05-25 |
CR10360A (es) | 2009-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201300121A1 (ru) | Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения | |
UY32989A (es) | Coposiciones terapéuticas concentradas de fosfolípidos | |
GT200600280A (es) | Composiciones y metodos para el tratamiento de sintomas relacionados con el ciclo | |
ECSP088904A (es) | Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina | |
CL2008002308A1 (es) | Compuestos heterociclos, moduladores de beta secretasa; composicion farmaceutica que los comprende; uso de los compuestos en la preparacion de medicamentos utiles para reducir la produccion de beta amiloide; y kit que contiene a uno de los compuestos, utiles para tratar enfermedades neurodegenerativas, tal como alzheimer. | |
GT200600028A (es) | Compuestos y composiciones como inhibidores de proteina kinasa | |
CL2007003523A1 (es) | Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad de pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso en el tratamiento profilactico o terapeutico del cancer | |
GT200900023A (es) | Formas farmacéuticas de dosificación oral que contienen un analgésico opioide. | |
BR112015020466A8 (pt) | inibidores de cdc7, seus usos, e composição farmacêutica | |
HN2012000023A (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
UA106636C2 (uk) | Морфолінотіазоли як позитивні алостеричні модулятори альфа 7 | |
AR086422A1 (es) | Metodo para el tratamiento de tumores solidos avanzados, volasertib | |
ECSP088801A (es) | Composicion farmaceutica que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b para el tratamiento de la neuralgia | |
AR055939A1 (es) | Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso | |
AR070392A1 (es) | Composiciones de tabletas de ranitidina de desintegracion oral y sus metodos de eleboracion | |
SV2010003773A (es) | 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos | |
PE20130147A1 (es) | Combinacion farmaceutica de teobromina y un agente antitusivo no opioide | |
CL2008000227A1 (es) | Composicion farmaceutica que comprende una combinacion de uso oral de tramadol y ketoprofeno; y uso en el tratamiento del dolor. | |
HN2010001775A (es) | Composicion farmaceutica oral que comprende la combinacion de una sal de keterolaco y vitaminas del complejo b | |
CL2009000264A1 (es) | Uso de una combinacion farmaceutica que comprende una sal de bis-tiazolio o uno de sus precursores y artemisina o uno de sus derivados, para el tratamiento y/o prevencion de la malaria severa; uso de la composicion farmaceutica y del kit farmaceutico que la comprenden. | |
AR067351A1 (es) | Combinacion de picotamida con nafronil | |
CL2008002485A1 (es) | Uso de gestagenos en combinacion con (6s)-5-metiltetrahidrofolato para el tratamiento de la endometriosis con reduccion de los efectos colaterales terapeuticos; procedimiento de preparacion de una composicion farmaceutica que comprende a dichos compuestos. | |
ECSP11011212A (es) | Nueva asociación de ingredientes activos que contienen un fármaco antiinflamatorio, no esteroideo y un derivado de colchicósido | |
CL2013003671A1 (es) | Composicion y combinacion farmaceutica que comprende ketorolaco y meloxicam; proceso para preparar la composicion; uso en el tratamiento de la inflamacion y el dolor. | |
PA8805501A1 (es) | Uso de la mequitazina en forma de racemato o de enantiómeros para la preparacion de un medicamento destinado al tratamiento o a la prevencion de patologias que implican los receptores histamínicos h4 |